Genes & Diseases

Genes & Diseases is a peer-reviewed open access journal published by KeAi together with Chongqing Medical University, launched in 2014 and focused on the molecular bases and experimental therapeutics of human diseases, with a 2025 Journal Impact Factor of 14.6《基因与疾病》是由（KeAi）与（重庆医科大学）合作出版的同行评审开放获取期刊，2014 年创刊，聚焦人类疾病的分子基础与实验治疗，2025 年影响因子为 14.6。

Scope

• It is a journal for molecular and translational medicine该刊是一本面向分子与转化医学的期刊。
• It focuses on the molecular bases and experimental therapeutics of human diseases其聚焦人类疾病的分子基础与实验治疗。
• It emphasises hypothesis-driven mechanistic studies relevant to pathogenesis该刊强调与发病机制相关的假设驱动机制研究。
• Its topics include cell proliferation and apoptosis and signal transduction其主题涵盖细胞增殖与凋亡以及信号转导。
• It covers stem cell biology and gene regulation and epigenetics该刊涵盖干细胞生物学以及基因调控与表观遗传学。
• It covers cancer biology and immunity and infection and neuroscience其涵盖肿瘤生物学、免疫与感染以及神经科学。
• It covers disease models and gene and cell-based therapies and regenerative medicine该刊涵盖疾病模型、基因与细胞治疗以及再生医学。

History

• It was launched in 2014 by Chongqing Medical University and Elsevier该刊于 2014 年由（重庆医科大学）与（Elsevier）共同创刊。
• Its first issue appeared in 2014 as volume 1, issue 1其创刊号为第 1 卷第 1 期，于 2014 年出版。^[1]
• It has been open access since its launch该刊自创刊起即为开放获取。
• It is published by KeAi on behalf of Chongqing Medical University该刊由（KeAi）代表（重庆医科大学）出版。
• Its Journal Impact Factor moved from 7.103 in 2021 and 9.4 in 2024 to 14.6 in 2025其影响因子由 2021 年的 7.103、2024 年的 9.4 变化到 2025 年的 14.6。
• In the 2025 Journal Citation Reports it ranks fourth among 192 journals in genetics and heredity在 2025 年期刊引证报告中，该刊在遗传学类别的 192 种期刊中位列第四。

Editors

• Its Editors-in-Chief are Ailong Huang and Tong-Chuan He其主编为 Ailong Huang 与 Tong-Chuan He。
• Ailong Huang is based at Chongqing Medical UniversityAilong Huang 任职于（重庆医科大学）。
• Tong-Chuan He is based at The University of Chicago Medical CenterTong-Chuan He 任职于（The University of Chicago Medical Center）。
• Zhenghe Wang and Xiaodong Zhao serve as Deputy Editors-in-ChiefZhenghe Wang 与 Xiaodong Zhao 担任副主编。
• Huijie Zhang serves as the Executive Managing EditorHuijie Zhang 担任执行责任编辑。
• It uses a single anonymous peer review system该刊采用单盲匿名同行评审制度。